Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

21.03.2024 - 11:20:37 | dgap.de

Dermapharm Holding SE / DE000A2GS5D8

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements


21.03.2024 / 11:20 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 28, 2024
Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857

Language: English
Date of disclosure: March 28, 2024
Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876


21.03.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

1864343  21.03.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1864343&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>

Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt kostenlos anmelden
Jetzt abonnieren.

DE000A2GS5D8 | DERMAPHARM HOLDING SE | boerse | 65010016 |